Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Comorbidities increase complication rates in patients having arthroplasty
Jain N, Gueller U, Pietrobon R, Bond T, Higgins L. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res 2005:232-8.
01.06.2005Comorbidities increase complication rates in patients having arthroplasty
01.06.2005Clin Orthop Relat Res 2005:232-8
Jain Nitin B, Gueller Ulrich, Pietrobon Ricardo, Bond Thomas K, Higgins Laurence D
Komplementärmedizin in der Onkologie - eine Einführung
Schlaeppi M, Jungi F, Cerny T. Komplementärmedizin in der Onkologie - eine Einführung. Swiss Medical Forum 2005; 5:686-694.
01.06.2005Komplementärmedizin in der Onkologie - eine Einführung
01.06.2005Swiss Medical Forum 2005; 5:686-694
Schlaeppi Marc, Jungi Felix, Cerny Thomas
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
Dengjel J, Rammensee H, Driessen C, Brock R, Kalbacher H, Brandenburg J, Altenberend F, Kreymborg K, Müller M, Kraus M, Reich M, Fischer R, Schoor O, Stevanovic S. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proceedings of the National Academy of Sciences of the United States of America 2005; 102:7922-7.
31.05.2005Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
31.05.2005Proceedings of the National Academy of Sciences of the United States of America 2005; 102:7922-7
Dengjel Jörn, Rammensee Hans-Georg, Driessen Christoph, Brock Roland, Kalbacher Hubert, Brandenburg Jens, Altenberend Florian, Kreymborg Katharina, Müller Margret, Kraus Marianne, Reich Michael, Fischer Rainer, Schoor Oliver, Stevanovic Stefan
Relation between blood lead levels and childhood anemia in India
Jain N, Laden F, Gueller U, Shankar A, Kazani S, Garshick E. Relation between blood lead levels and childhood anemia in India. Am J Epidemiol 2005; 161:968-73.
15.05.2005Relation between blood lead levels and childhood anemia in India
15.05.2005Am J Epidemiol 2005; 161:968-73
Jain Nitin B, Laden Francine, Gueller Ulrich, Shankar Anoop, Kazani Shamsah, Garshick Eric
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma
Jörger M, Huitema A, Meenhorst P, Schellens J, Beijnen J. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma. Cancer chemotherapy and pharmacology 2005; 55:488-96.
01.05.2005Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma
01.05.2005Cancer chemotherapy and pharmacology 2005; 55:488-96
Jörger Markus, Huitema A D R, Meenhorst P L, Schellens J H M, Beijnen J H
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
Colleoni M, Veronesi A, Holmberg S, Erzen D, Forbes J, Murray E, Thürlimann B, Simoncini E, Pagani O, Collins J, Crivellari D, Rudenstam C, Lindtner J, Price K, Castiglione-Gertsch M, Coates A, Gelber R, Li S, Goldhirsch A. Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Ann Oncol 2005; 16:716-25.
01.05.2005Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
01.05.2005Ann Oncol 2005; 16:716-25
Colleoni M, Veronesi A, Holmberg S, Erzen D, Forbes J, Murray E, Thürlimann Beat, Simoncini E, Pagani O, Collins J, Crivellari D, Rudenstam C-M, Lindtner J, Price K N, Castiglione-Gertsch M, Coates A S, Gelber R D, Li S, Goldhirsch A
Sample size matters: a guide for surgeons
Gueller U, Oertli D. Sample size matters: a guide for surgeons. World J Surg 2005; 29:601-5.
01.05.2005Sample size matters: a guide for surgeons
01.05.2005World J Surg 2005; 29:601-5
Gueller Ulrich, Oertli Daniel
Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature
D'Addario G, Pintilie M, Leighl N, Feld R, Cerny T, Shepherd F. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005; 23:2926-36.
01.05.2005Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature
01.05.2005Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005; 23:2926-36
D'Addario Giannicola, Pintilie Melania, Leighl Natasha B, Feld Ronald, Cerny Thomas, Shepherd Frances A
Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma.
Hofer S, Seeger H, Rordorf T, Knuth A, Janzer R. Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma. J Neurooncol 2005; 72:239.
01.05.2005Undifferentiated sarcoma arising in the brain, 23 years after curative treatment of an ependymoma.
01.05.2005J Neurooncol 2005; 72:239
Hofer Silvia, Seeger Harald, Rordorf Tamara, Knuth Alexander, Janzer Robert
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity
Nieuwenhuis E, Blumberg R, Dranoff G, Strominger J, Balk S, Taniguchi M, Exley M, Scheper R, Gillessen Sommer S, Wilson S. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Experimental dermatology 2005; 14:250-8.
01.04.2005CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity
01.04.2005Experimental dermatology 2005; 14:250-8
Nieuwenhuis Edward E S, Blumberg Richard S, Dranoff Glenn, Strominger Jack L, Balk Steven P, Taniguchi Masaru, Exley Mark A, Scheper Rik J, Gillessen Sommer Silke, Wilson S Brian
Cryotherapy after ACL reconstruction: a meta-analysis
Raynor M, Pietrobon R, Gueller U, Higgins L. Cryotherapy after ACL reconstruction: a meta-analysis. J Knee Surg 2005; 18:123-9.
01.04.2005Cryotherapy after ACL reconstruction: a meta-analysis
01.04.2005J Knee Surg 2005; 18:123-9
Raynor Mathew C, Pietrobon Ricardo, Gueller Ulrich, Higgins Laurence D
Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity
Baechle D, Cansier A, Fischer R, Brandenburg J, Burster T, Driessen C, Kalbacher H. Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity. Journal of peptide science : an official publication of the European Peptide Society 2005; 11:166-74.
01.03.2005Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity
01.03.2005Journal of peptide science : an official publication of the European Peptide Society 2005; 11:166-74
Baechle D, Cansier A, Fischer R, Brandenburg J, Burster T, Driessen Christoph, Kalbacher H
Von Hippel-Lindau disease--a rare disease important to recognize
Jörger M, Köberle D, Neumann H, Gillessen Sommer S. Von Hippel-Lindau disease--a rare disease important to recognize. Onkologie 2005; 28:159-63.
01.03.2005Von Hippel-Lindau disease--a rare disease important to recognize
01.03.2005Onkologie 2005; 28:159-63
Jörger Markus, Köberle Dieter, Neumann Hartmut P H, Gillessen Sommer Silke
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study
Ravaud A, Cerny T, Terret C, Wanders J, Bui B, Hess D, Droz J, Fumoleau P, Twelves C. Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study. European journal of cancer (Oxford, England : 1990) 2005; 41:702-7.
01.03.2005Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study
01.03.2005European journal of cancer (Oxford, England : 1990) 2005; 41:702-7
Ravaud Alain, Cerny Thomas, Terret Catherine, Wanders Jantien, Bui Binh Nguyen, Hess Dagmar, Droz Jean-Pierre, Fumoleau Pierre, Twelves Chris
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
Colleoni M, Thürlimann B, Crivellari D, Murray E, Mendiola C, Pagani O, Castiglione-Gertsch M, Coates A, Price K, Fey M, Collins J, Zahrieh D, Gelber R, Holmberg S, Mattsson J, Rudenstam C, Lindtner J, Erzen D, Snyder R, Goldhirsch A. Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. JCO 2005; 23:1390-400.
01.03.2005Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
01.03.2005JCO 2005; 23:1390-400
Colleoni Marco, Thürlimann Beat, Crivellari Diana, Murray Elizabeth, Mendiola Caesar, Pagani Olivia, Castiglione-Gertsch Monica, Coates Alan S, Price Karen, Fey Martin F, Collins John, Zahrieh David, Gelber Richard D, Holmberg Stig B, Mattsson Jan E, Rudenstam Carl-Magnus, Lindtner Jurij, Erzen Darja, Snyder Raymond, Goldhirsch Aron
Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients
Langer I, Kocher T, Gueller U, Torhorst J, Oertli D, Harder F, Zuber M. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients. Breast Cancer Res Treat 2005; 90:85-91.
01.03.2005Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients
01.03.2005Breast Cancer Res Treat 2005; 90:85-91
Langer I, Kocher T, Gueller Ulrich, Torhorst J, Oertli D, Harder F, Zuber M
Letale Polypharmazie bei einem Hypertoniker - Erwiderung
Diethelm M, Jörger M. Letale Polypharmazie bei einem Hypertoniker - Erwiderung. Deutsche medizinische Wochenschrift (1946) 2005; 130:413-414.
17.02.2005Letale Polypharmazie bei einem Hypertoniker - Erwiderung
17.02.2005Deutsche medizinische Wochenschrift (1946) 2005; 130:413-414
Diethelm Markus, Jörger Markus
Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)
Ghielmini M, Cerny T, Bargetzi M, Ketterer N, Stahel R, Pichert G, Schefer H, Betticher D, Fey M, Waltzer U, Bertoni F, Cogliatti S, Schmitz S, Swiss Group for Clinical Cancer Research. Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005; 23:705-11.
01.02.2005Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)
01.02.2005Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005; 23:705-11
Ghielmini Michele, Cerny Thomas, Bargetzi Mario, Ketterer Nicolas, Stahel Rolf, Pichert Gabriella, Schefer Hubert, Betticher Daniel C, Fey Martin F, Waltzer Ursula, Bertoni Francesco, Cogliatti Sergio, Schmitz Shu-Fang Hsu, Swiss Group for Clinical Cancer Research
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
Borner M, Roth A, Lanz D, Brauchli P, Honegger H, Köberle D, Herrmann R, Rauch D, Saletti P, Wernli M, Popescu R, Dietrich D, Bernhard J, Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:282-8.
01.02.2005A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
01.02.2005Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:282-8
Borner M M, Roth A D, Lanz D, Brauchli P, Honegger H, Köberle Dieter, Herrmann R, Rauch D, Saletti P, Wernli M, Popescu R, Dietrich D, Bernhard J, Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland
[Sentinel node biopsy in breast cancer: techniques and indications]
Haid A, Knauer M, Köberle-Wührer R, Wenzl E. [Sentinel node biopsy in breast cancer: techniques and indications]. Wien Klin Wochenschr 2005; 117:121-8.
01.02.2005[Sentinel node biopsy in breast cancer: techniques and indications]
01.02.2005Wien Klin Wochenschr 2005; 117:121-8
Haid Anton, Knauer Michael, Köberle-Wührer Roswitha, Wenzl Etienne